PRESS RELEASE
10 Years Old Already! McDermott’s Paris Office Celebrates the Anniversary of its Founding
June 24, 2021
Read time: 5 min
McDermott Will & Emery opened its doors in Paris in May 2011.
In just 10 years, the firm has become a key player in Paris and made an indelible mark on the French market.
10 Years of Entrepreneurship, Excellence and Team Spirit
In 2011, McDermott started out onto the Paris market with 10 lawyers including 4 partners. 10 years later, the office is 90 lawyers strong, including 22 partners. Recommended by international and French legal rankings in all of its practice areas, the Paris office is in line with the firm’s global positioning, having developed market leading expertise in private equity and life sciences, among others. McDermott is now one of the 10 largest US firms in the French market.
Jacques Buhart, who founded the Paris office alongside three other partners: “The dimension of entrepreneurship and the desire to be part of a project that is both French and international, guided the opening of the firm in Paris. By capitalizing on a team that knew each other and shared strong values of excellence and respect, we have integrated into the market and built high-level profiles in both legal counsel and litigation over the past 10 years. A firm is defined by the men and women that make it up. ”
In October 2019, Grégoire Andrieux, who joined the firm in 2015, succeeded Jacques Buhart as Managing Partner.
Grégoire Andrieux, Managing Partner: ” In 10 years, many lawyers with diverse and complementary backgrounds have participated in the McDermott adventure in France to build a broad range of business law services for our clients. They have advised and defended a large number of French and foreign funds, listed and unlisted companies, managers and institutional investors. This birthday is a special occasion to thank all the teams for their commitment and our clients for their trust. ”
A confirmed ambition for the next 10 years
With 12 offices in the United States, McDermott Will & Emery only began its expansion in Europe in the 2000s. The French team has taken the successful step of developing at a fast track in France, meeting the ambitions of the international firm and the requirements of a highly competitive market.
To go further, the managing partner is investing in a synergy of expertise, an assertive industry positioning in key areas such as health and life sciences, energy, transport, telecoms, infrastructure or technology, a new generation with a strong diversity and harmony, and the right balance between legal advice and litigation.
Grégoire Andrieux adds: ” We are building on a solid foundation and strong team spirit. We intend to continue our development by always being attentive to the new needs of our clients, whatever their project. We will continue to combine our skills to meet to their challenges, to adapt to situations of growth, crisis or reorganisation, and to leverage our international capabilities which are an essential part of our approach. To this end, we will strengthen our teams and harness our internal talent pool by focusing on trust, an entrepreneurial spirit and excellence in client service. ”
Key Figures – 10 Years of McDermott in Paris :
- 100 people
- 90 lawyers, including 22 partners and 7 counsels, 18 partners recruited and 7 partners appointed since the creation of the office
- 14 nationalities
- 9 working languages
- Median age: 37 years old
- 54% /46% male to female split (Legal Professionals)
- Pro Bono Initiatives (Médecins sans frontières, Covidliste, Emmaüs, Face au monde, Tech For Good France)
- Broad-range of services including: mergers & acquisitions / stock exchange law, private equity, financing, competition, tax, restructuring, public & regulatory law, employment law, health and life sciences, commercial litigation & criminal business law, data protection & cybersecurity, intellectual property
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective — and often unexpected — solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
McDermott Advises Corlieve Therapeutics on the Sale of its Lead Program to uniQure
PRESS RELEASE
McDermott Advises Corlieve Therapeutics on the Sale of its Lead Program to uniQure
June 23, 2021
Read time: 3 min
McDermott Will & Emery has advised Corlieve Therapeutics on its sale to uniQure, with its lead program, a gene therapy approach to treat Temporal Lobe Epilepsy (TLE), the most common form of focal epilepsy.
Corlieve Therapeutics is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders.
uniQure is a leading gene therapy company advancing transformative therapies for patients with severe medical needs.
The McDermott team that advised Corlieve Therapeutics comprised:
- Emmanuelle Trombe, partner, Katya Ascher, counsel, Laëtitia de Dinechin and Pascaline Sagot, associates, on Corporate and Life Sciences aspects ;
- Heidi Steele, partner in Chicago, on securities aspects ;
- Côme de Saint-Vincent, associate, on tax aspects, and
- Sabine Naugès, partner, and Charlotte Michellet, counsel, on Public Law aspects.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective — and often unexpected — solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
Schulte Roth & Zabel Announces Addition of Leading Finance Lawyer Gregory Ruback
PRESS RELEASE
Schulte Roth & Zabel Announces Addition of Leading Finance Lawyer Gregory Ruback
June 21, 2021
Read time: 4 min
Schulte Roth & Zabel (SRZ) announces the addition of Gregory Ruback as a partner in the Finance & Derivatives Group, resident in the firm’s New York office. He joins SRZ from DLA Piper, where he was a partner in the Finance Group.
“Greg is a market-leading lawyer with specialist expertise, and we are thrilled to welcome him to SRZ,” said Craig Stein, co-head of the Finance & Derivatives Group. “Greg’s substantial expertise across a broad range of industries and asset classes will further enhance our strong capabilities and client offerings,” said Boris Ziser, co-head of the Finance & Derivatives Group and a member of the firm’s Executive Committee.
Mr. Ruback has extensive experience across a variety of industries and jurisdictions representing private equity firms, hedge funds, public and private companies, banks, BDCs, alternative lenders and other financial institutions in domestic and international bilateral, club and syndicated financings. Additionally, he has substantial experience with acquisition financings, financings of recapitalizations, bridge and takeout financings, multiple lien credit facilities, mezzanine facilities, unitranche financings, asset-based lending and other financings. Mr. Ruback also has significant experience with workout and restructuring matters.
“We are delighted to have Greg join SRZ. He is a highly skilled lawyer with an outstanding reputation for providing strategic counsel,” said David Efron, SRZ co-managing partner and co-head of the Investment Management Group. “Greg is an excellent addition to our leading finance and derivatives group, which represents some of the most prominent players in the market. His arrival will further strengthen our deep bench,” commented Marc Elovitz, SRZ co-managing partner and chair of the Investment Management Regulatory & Compliance Group.
“SRZ is known in the industry as a cutting-edge, commercial firm with a long tradition of providing best-in-class client service, and I am thrilled to be a part of this team,” said Mr. Ruback, who received his J.D. from Fordham University School of Law and his B.S. from Babson College.
SRZ’s finance and derivatives lawyers represent a wide range of market participants, including private investment funds, managers, issuers, purchasers and sellers of assets, underwriters, placement agents, borrowers and investors. They structure and negotiate a variety of complex structured finance and securitization transactions, advising on a diverse breadth of matters, including specialty finance transactions, collateralized loan obligations (CLOs) and asset-backed securitizations, as well as regulatory capital offerings.
Media Contact
CarVal Investors Raises $3.6 Billion Credit Fund
PRESS RELEASE
CarVal Investors Raises $3.6 Billion Credit Fund
June 17, 2021
Read time: 3 min
Schulte represented CarVal Investors in raising $3.6 billion for CVI Credit Value Fund V (CVF V), exceeding its original hard cap size by 20%. CVF V is focused on identifying distressed and credit intensive assets within its core strategies of loan portfolios, corporate securities, structured credit and hard assets. CarVal Investors is an established global alternative investment manager focused on distressed and credit-intensive assets and market inefficiencies with approximately $10 billion in assets under management in corporate securities, loan portfolios, structured credit and hard assets.
The Schulte team advising CarVal was led by investment management partner David Nissenbaum. The team also included investment management regulatory and compliance partner Anna Maleva-Otto; investment management special counsel Shawn McCune, associates Alexis Marion and Grace Willingham and former associate Bojun Xu and law clerk Shelby Anderson; tax partners David Griffel, Philippe Benedict, Nick Fagge, special counsel Christine Harlow, associate Olesia Zakon and law clerk Jacob Gach; and employment and employee benefits partner David Cohen.
Media Contact
McDermott Comment | Ban On Commercial Evictions To Be Extended Until 2022
PRESS RELEASE
McDermott Comment | Ban On Commercial Evictions To Be Extended Until 2022
June 18, 2021
Read time: 3 min
Aymen Mahmoud, partner at law firm McDermott Will & Emery, said:
“While the financial markets continue to make significant investments in financial restructuring professionals ahead of an expected wave of insolvencies, we can expect lawmakers to extend latitude to companies to protect their going concern value. This breathing space will be very helpful to companies trying to best understand the economic landscape that they are returning to and none more so than companies in the retail sector. It may well be that the government has decided to act here because there has historically been a significant delay between market-wide financial decline and a corresponding reduction in lease costs as landlords try to maximize periods of profitability.”
Media Contact
McDermott Represents USAA in its Acquisition of Noblr, Inc.
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Represents USAA in its Acquisition of Noblr, Inc.
June 16, 2021
Read time: 3 min
International law firm McDermott Will & Emery represented United Services Automobile Association (USAA), a leading provider of insurance, investing, and banking solutions to members of the US military, veterans, and their families, in its acquisition of Noblr, Inc. (Noblr), subject to regulatory approval. Noblr is a California-based insurtech firm offering smart car insurance using a phone application to reward its members’ good driving habits based on factors such as miles driven, time of driving and quality of driving.
The acquisition is expected to expand USAA’s offerings by adding a usage-based insurance option to USAA members. Usage-based insurance products combine usage and behavioral factors to create a pay-as-you-go personalized pricing. This acquisition should result in cost-savings benefits for USAA’s military service members who are highly mobile and frequently deployed.
- This transaction was signed on June 9, 2021, and is expected to close this year, subject to regulatory approval.
- McDermott Will & Emery acted as legal counsel to USAA.
- Read USAA’s press release here.
- The McDermott team was led by Wilson Chu and Michael Halsband and included Diego Gómez-Cornejo, Thaddeus Chase, Marisa Young and Matthew Chen. Additional support included Shawn Helms, Nickou Oskoui, Brian Long, Tiantian Chen, Niraj Patel, Alex Ruiz, Erin Turley, Teal Trujillo, Michelle Strowhiro, Marjorie Soto, Timothy (Ty) Carson and Graham Hyman.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
McDermott Provides Strategic Healthcare Regulatory Counsel to Medline; Supports Investment Partnership from Blackstone, Carlyle and Hellman & Friedman
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Provides Strategic Healthcare Regulatory Counsel to Medline; Supports Investment Partnership from Blackstone, Carlyle and Hellman & Friedman
June 15, 2021
Read time: 4 min
Leading international law firm McDermott Will & Emery provided Medline Industries, Inc. with strategic healthcare regulatory counsel in the sale of the majority of its equity to a consortium of private equity firms led by Blackstone, Carlyle and Hellman & Friedman. McDermott’s team of transactions and healthcare lawyers prepared and guided the Medline team through a rigorous and expedited due diligence review conducted by the various bidders. The transaction, announced on June 5, 2021, is valued at more than $30 billion and is the largest leveraged buyout since the financial crisis.
Medline is the largest privately-held manufacturer and distributor of healthcare supplies in the United States, and following the close of the transaction, Medline will remain a privately held, family-led company. The company plans to use the new resources from the partnership to expand its product offerings, accelerate international expansion and continue to make new infrastructure investments to strengthen its global supply chain.
Medline partners with healthcare providers around the world, delivering products and solutions that reduce costs, increase supply chain efficiency, and improve the quality of care. The breadth of the company’s product portfolio and its dedication to customer service, responsiveness, and partnership provide significant value for its customers.
Goldman Sachs & Co. LLC acted as lead financial advisor and BDT & Company, LLC acted as financial advisor. Wachtell, Lipton, Rosen & Katz acted as lead legal advisor to Medline.
The McDermott team was led by Byron Kalogerou and included James Cannatti, Jiayan Chen, Rebecca Dufur, David Gacioch, Jana Grieb, James Kim, Brian Long, Tony Maida, Brian Malkin, Anisa Mohanty, Romain Perray, Amy Pimentel, Joan Polacheck, Mac Routh and Danielle Scheer.
McDermott Will & Emery is the nation’s leading health law firm. The Health Industry Advisory group is the only health practice to receive top national rankings from U.S. News – Best Lawyers “Best Law Firms,” Chambers USA, The Legal 500 US and Law360. The practice was also recognized by Chambers as “Health Team of the Year” in 2010, 2013, 2017 and 2019. McDermott has also held the top spot in PitchBook’s League Tables as the most active firm for healthcare private equity since 2017. Pitchbook also ranked McDermott #3 in PE in the US and #5 in PE globally.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact
Schulte Roth & Zabel Releases June 2021 Private Funds Market Trends Report
PRESS RELEASE
Blank Media template
Read time: 2 min
Media Contact
McDermott berät SIGNA Sports United bei De-SPAC-Transaktion mit Yucaipa Acquisition Corporation
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott berät SIGNA Sports United bei De-SPAC-Transaktion mit Yucaipa Acquisition Corporation
14. Juni 2021
Read time: 3 min
Frankfurt a.M., 14. Juni 2021 – McDermott Will & Emery hat die SIGNA Sports United GmbH (SSU) im Rahmen des Zusammenschlusses mit der Yucaipa Acquisition Corporation (YAC), einer börsennotierten Special Purpose Acquisition Company (SPAC), beraten. Der Zusammenschluss umfasst auch die Übernahme des britischen Online-Fahrradhändlers Wiggle/CRC Group.
Im Zuge dieser sogenannten De-SPAC-Transaktion wird die Gruppenstruktur der SSU grundlegend geändert. Nach Abschluss der Transaktion werden die Aktien der SSU an der NYSE gehandelt werden; die SSU wie auch die börsennotierte TopCo werden ihren Unternehmenssitz in Berlin haben.
Ein Team von McDermott unter Federführung von Dr. Kian Kauser und Sebastian Bonk stand der SIGNA Sports United GmbH und deren Mehrheitsgesellschafterin SIGNA International Sports Holding GmbH bei der gesellschafts- und steuerrechtlichen Strukturierung der Unternehmensgruppe ebenso wie bei der Übernahme der Wiggle/CRC Group beratend zur Seite.
Die Transaktion unterstreicht die starke Position von McDermott Will & Emery bei der gesellschaftsrechtlichen und steuerrechtlichen Beratung komplexer grenzüberschreitender Transaktionen.
Berater SIGNA Sports United GmbH und SIGNA International Sports Holding GmbH:
McDermott Will & Emery, Düsseldorf/Frankfurt: Dr. Kian Tauser (Steuerrecht, Frankfurt), Sebastian Bonk (Associate, Corporate/M&A, Düsseldorf; beide Federführung), Dr. Matthias Kampshoff, Dr. Philipp Grenzebach (beide Corporate/M&A, Düsseldorf), Dr. Heiko Kermer (Steuerrecht, Frankfurt), Eleanor West (Corporate/M&A, London), Dr. Jan Hückel (Corporate/M&A, Düsseldorf; beide für Übernahme Wiggle/CRC Group), Christian Krohs (Kartellrecht, Düsseldorf); Associates: Dr. Florian Schiefer (Steuerrecht, Frankfurt), Sebastian Klein (Corporate/M&A, Düsseldorf), Daniel Ross (Corporate/M&A, London), Carina Kant (Kartellrecht, Düsseldorf)
McDermott Will & Emery ist eine führende internationale Anwaltssozietät. Mit über 1.200 Rechtsanwälten sind wir an 21 Standorten weltweit vertreten: Atlanta, Boston, Brüssel, Chicago, Dallas, Düsseldorf, Frankfurt a. M., Houston, Köln, London, Los Angeles, Miami, Mailand, München, New York, Orange County, Paris, San Francisco, Silicon Valley, Washington, D.C. und Wilmington. Die deutsche Praxis wird von der McDermott Will & Emery Rechtsanwälte Steuerberater LLP geführt. www.mwe.com
Media Contact
McDermott Lawyers Recognized as Law360 Rising Stars
AWARDS & RANKINGS / PRESS RELEASE
McDermott Lawyers Recognized as Law360 Rising Stars
June 11, 2021
Read time: 4 min
International law firm McDermott Will & Emery is pleased to announce that partners Lisa Mazur and Christopher Gladbach have been named to Law360’s Rising Stars for their outstanding work in the areas of health care and project finance.
Based in the Chicago office, Lisa Mazur is co-chair of McDermott’s Digital Health industry group and leads the Telehealth affinity group. Lisa advises a variety of health care providers and technology companies involved in “digital health” – the intersection of health software applications, analytical tools, medical technology and electronic data assets enabled by the Internet and mobile devices – on the applicable legal and regulatory infrastructure, with a particular focus on telehealth, telemedicine, mobile health and consumer wellness programs. Lisa helps her clients identify and understand timely legal issues, and develop and implement practical, forward-thinking compliance and revenue strategies, and meet head-on the complex and still-evolving digital health regulatory landscape.
She also advises providers on professional licensure, scope of practice, nonprofit corporate governance matters, tax-exemption issues, conflict of interest compliance, clinical research compliance and overall corporate compliance effectiveness as well as counsels on leading-edge health industry relationship formation and realignments, with a focus on development of provider networks and strategies for achieving greater collaboration among providers.
Christopher Gladbach is a partner in McDermott’s corporate practice and is based in Washington, D.C.. Chris works with energy clients in structuring complex equity and debt investments. He advises buyers and sellers in the power sector on mergers and acquisitions and joint ventures, and provide guidance on the development of large-scale energy projects. He assists clients in mitigating and allocating risk associated with these transactions in pursuit of their primary business and financial objectives.
Chris also has extensive experience involving the development and financing of United States Department of Defense (DoD) energy projects. He counsels developers, purchasers, lenders and tax equity investors in government contracts and structuring project development and financing arrangements to account for unique risks. In addition, Chris represents market-leading private equity funds and institutional investors in power asset transactions, and understands the unique challenges and opportunities that these clients face.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
